Understanding the mechanisms behind elevated chronic immune inflammation in HIV, and in particular its relation to IL-6 levels in the blood, may inform strategies to target immune inflammation and persistent dyslipidemias that contribute to CVD risk and other sources of morbidity [6] and mortality in chronic HIV infection. This evidence concerns the gene IL6 and HIV infectious disease.